Unit details
HMM302 - Innovations in Medical Biotechnology
| Offered at: | (G) |
|---|---|
| Credit point(s): | 1 |
| Offerings: | Trimester 1 |
| EFTSL value: | 0.125 |
| Unit chair: | A Ward |
| Prerequisite: | HMM201 |
| Contact hours: | 3 x 1 hour lectures per week and 1 x 1 hour tutorial/workshop per week |
| Note: Unit commences in Trimester 1 2015. Online teaching methods require internet access. Please refer to the most current computer specifications. | |
Content
This unit provides a comprehensive overview of the business of medical biotechnology, including innovation management, funding, and the regulatory framework relevant to the industry. It will also explore risk management, and the societal and ethical issues pertinent to medical biotechnology in real-world scenarios.
Assessment
Written report 1 (800 words) 20%, written report 2 (800 words) 20%, written report 3 (800 words) 20%, examination (2 hours) 40%
Prescribed texts
Crommelin, D. J. A., Sindelar R. D., Meibohm, B. 2008. Pharmaceutical Biotechnology: Fundamentals and Applications, 3rd edn, Informa Healthcare, New York, US
Unit Fee Information
